Zirabev - supply shortage
Resolved
bevacizumab
ShortageHuman
Shortage information
The shortage affecting Zirabev has been resolved and the information and recommendations which were issued during the shortage no longer apply.
Key facts
- Medicines affected
- Zirabev
- Supply shortage status
- Resolved
- International non-proprietary name (INN) or common name
- bevacizumab
- Therapeutic area (MESH)
- Colorectal Neoplasms
- Breast Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Uterine Cervical Neoplasms
- Pharmaceutical forms affected
- Concentrate for solution for infusion
- Strengths affected
- 100mg/4ml
- 400mg/16ml
Key dates
- First published
- Last updated